Regulation of Non-THC Cannabinoids

Rod Kight Related Seminars and Products

Attorney | Author | Advocate

Kight Law Office, PC

Rod is a cannabis business law attorney. Based in North Carolina and Mexico, Rod represents legal cannabis businesses throughout the world and is editor and chief writer of the Kight On Cannabis law blog. Rod is the author of “Cannabis Business Law-What You Need to Know”, published by Aspatore Books. He has served on the advisory board for the American Journal of Endocannabinoid Medicine, for which he has also written a legal column. Rod also created the “Source Rule”, which is widely regarded as a primary legal foundation for the contemporary hemp market in cannabinoids and other cannabis materials.

Rod is frequently quoted on cannabis matters by trade publications and major media outlets including the Wall Street Journal, Time, Politico, and Business Insider. Additionally, Rod has been listed in MG Magazine's list of "30 Powerful Litigators", Hemp Connoisseur Magazine’s list of “100 People You Should Know”, and High Time's "2020 Leaders in Cannabis Law." He is part of the legal teams in two high-profile cases against the DEA and the Texas Department of State Health Services regarding hemp extracts, has drafted and presented cannabis legislation to a foreign head of state, is a member of the board of directors of a publicly traded Canadian cannabis and psychedelics company, testified to the FDA about CBD and cannabis compounds, and is a partner in a Mexican import-export company focused on legal cross-border hemp transactions. Rod routinely advises in-house counsel and C-suite level executives on cannabis issues. He has discussed cannabis legal issues in numerous seminars to lawyers, business executives, and public officials and is regularly asked to be a guest speaker on US and inter- national podcasts about cannabis and psychedelics.

Rod is a strong believer in cannabis for personal and medical use after using it successfully during chemotherapy treatments for cancer (he is in remission). He has been an attorney advocate for NORML and has also been a member of the International Cannabis Bar Association, the National Cannabis Industry Association, the Hemp Industries Association, and the Southeast Hemp Association.

Andrew Hall Related Seminars and Products

Green Scientific Labs

Dr. Hall is widely regarded as one of the most knowledgeable and outside the box thinkers in the cannabis industry. Having received his Bachelor of Science degree with a double major in Chemistry and Biology, Hall went on to pursue both his Masters and PhD at Florida Atlantic University, majoring in Chemistry with a focus on natural products chemistry.

Dr. Hall possesses a vast amount of experience in the laboratory space, holding senior positions in toxicology labs, clinical labs, and cannabis labs. He has been instrumental in leading labs through successful ISO 17025 accreditation in multiple states and most recently, at Green Scientific Labs in FL.

Daniel Young Related Seminars and Products

Grassland Botanicals

Daniel L. Young, PhD has worked at the forefront data sciences with a focus on healthcare innovation and systems biology for over seventeen years focusing on biomedical, machine learning, machine vision, pharmaceutical, diagnostic and healthcare applications.  Dr. Young began his research career at the Harvard Biomotion Laboratory, Massachusetts General Hospital where he designed novel devices to aid in human motion and rehabilitation for patients.  While a researcher and postdoctoral associate at Harvard-MIT Division of Health Sciences and Technology, Dr. Young investigated novel optimal control system strategies for biomedical applications inspired by his research of neural networks and synaptic plasticity.  His research was applied to medical treatments and the control of complex nonlinear systems.  

In his pursuit of advancing our fundamental understanding of complex, heterogeneous diseases, diagnostic approaches, and response to treatments, Dr. Young’s research utilizing advanced computational and machine learning algorithms has included the study of diabetes, respiratory disorders, neuroscience, oncology, infectious diseases, bone disorders, autoimmunity, renal disease, and anemia.  Dr. Young and one of his colleagues were editors of a pioneering book on systems biology published in 2011 by Wiley, Inc., integrating the latest advancements in personalized medicine and systems approaches to the delivery of healthcare.  

Dr. Young helped develop predictive biosimulations at Entelos, Inc. focused on quantitative models for the discovery and validation of drug targets, identification of biomarkers, proactive and personalized medicine, design of clinical trials, and ultimately advancing the effectiveness of preventative, therapeutic and monitoring solutions for patients.  He founded Lemma Consulting focused on data-driven approaches to enhance novel technologies. And most recently, Dr. Young founded Grassland Botanicals to focus on natural plant-based luxury products for improving wellness.

Nathalie Bougenies Related Seminars and Products

Associate

Miller Nash LLP

Located in Washington, D.C., Nathalie Bougenies advises domestic and international clients on a variety of business and corporate transactions. She assists companies with a wide range of legal issues, including the sale, distribution, marketing, labeling, and importation and exportation of products, and also conducts due diligence to assure compliance with applicable U.S. and foreign laws and regulations. Nathalie has worked on a wide variety of corporate and business transactions, including mergers & acquisitions, joint ventures, and equity closings, and regularly counsels on general business contracts, including white label agreements and licensing agreements.

Additionally, Nathalie helps clients navigate the complex landscape of highly regulated industries, including maritime, cannabis, and hemp. She assists maritime clients with their transactional needs, such as contract drafting and negotiation, regulatory compliance, and towing agreements. Nathalie frequently speaks on regulatory issues related to hemp and cannabis, and has made national media appearances, including on NPR’s “Marketplace.” She also authors a biweekly column for Above the Law discussing cannabis policy and regulation.

During law school, Nathalie served as a Fellow with the U.S. Chamber of Commerce Global Innovation Policy Center in Washington, D.C., where she researched complex IP issues, including counterfeiting and patent reforms, and advocated on behalf of Fortune 500 companies for stronger IP rights and global enforcement.

Nathalie was born and raised in Belgium and has lived and studied in Africa, Asia, Europe, and North America. She utilizes her broad international background to assist overseas clients with their foreign direct investment into the United States and offers unique and valuable insight to clients in their cross-border transactions.

Ian Stewart Related Seminars and Products

Chair of National Cannabis Law Practice

Wilson Elser LLP

Ian is the Regional Managing Partner of Wilson Elser’s Los Angeles office. He is founder and co-chair of the firm’s Cannabis and Hemp Law practice, where he leads a national multi-disciplinary team of lawyers who serve all aspects of the cannabis and hemp industries, as well as financial institutions and insurance companies that service those industries.  

Ian works with licensed cannabis operators throughout the country to comply with their obligations under the law and to develop risk management best practices. He advises Fortune 500 companies on risk management involving hemp-derived CBD and the interplay with U.S. food and drug laws. Ian assists insurance companies on cannabis-related underwriting practices and the development of new policy forms. He also works with financial institutions and professional services firms on best practices for operating in a challenging regulatory environment.  

Ian has achieved a national reputation as a distinguished cannabis attorney and has been named to the prestigious Chambers USA guide in Cannabis Law (2020-2022). He is a member of the Advisory Board of the International Cannabis Bar Association (INCBA) and participates on the Policy Council of the National Cannabis Industry Association (NCIA). Ian also sits on the Executive Committee of the Los Angeles County Bar Association’s Cannabis Section and is chair emeritus of NCIA’s Risk Management and Insurance Committee. He is one of MG Magazine’s “30 Powerful Cannabis Attorneys You Should Know” and is listed within Cannabis Reports’ “10 Powerful Marijuana Lawyers in California.” Ian has also been named by National Law Review as “Go-To Thought Leader” in 2018 and 2021 for his publications on cannabis law and policy. 

By way of background, Ian has defended complex litigation in state and federal courts for more than 25 years with a focus on practice areas relevant to the cannabis industry, including product liability, complex general casualty, transportation, data privacy and intellectual property litigation. Ian received his B.A. from Washington University in St. Louis, and his JD from Saint 

Louis University School of Law. He has been with Wilson Elser for the past 22 years.